全文获取类型
收费全文 | 8674篇 |
免费 | 364篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 263篇 |
妇产科学 | 73篇 |
基础医学 | 1303篇 |
口腔科学 | 158篇 |
临床医学 | 509篇 |
内科学 | 2563篇 |
皮肤病学 | 182篇 |
神经病学 | 725篇 |
特种医学 | 232篇 |
外科学 | 1131篇 |
综合类 | 19篇 |
预防医学 | 210篇 |
眼科学 | 99篇 |
药学 | 701篇 |
中国医学 | 43篇 |
肿瘤学 | 824篇 |
出版年
2023年 | 35篇 |
2022年 | 48篇 |
2021年 | 145篇 |
2020年 | 55篇 |
2019年 | 100篇 |
2018年 | 125篇 |
2017年 | 93篇 |
2016年 | 138篇 |
2015年 | 143篇 |
2014年 | 192篇 |
2013年 | 255篇 |
2012年 | 453篇 |
2011年 | 474篇 |
2010年 | 283篇 |
2009年 | 257篇 |
2008年 | 525篇 |
2007年 | 598篇 |
2006年 | 549篇 |
2005年 | 597篇 |
2004年 | 618篇 |
2003年 | 617篇 |
2002年 | 656篇 |
2001年 | 100篇 |
2000年 | 51篇 |
1999年 | 135篇 |
1998年 | 166篇 |
1997年 | 125篇 |
1996年 | 144篇 |
1995年 | 126篇 |
1994年 | 141篇 |
1993年 | 146篇 |
1992年 | 95篇 |
1991年 | 84篇 |
1990年 | 74篇 |
1989年 | 81篇 |
1988年 | 49篇 |
1987年 | 47篇 |
1986年 | 40篇 |
1985年 | 39篇 |
1984年 | 49篇 |
1983年 | 44篇 |
1982年 | 63篇 |
1981年 | 56篇 |
1980年 | 36篇 |
1979年 | 31篇 |
1978年 | 26篇 |
1977年 | 19篇 |
1976年 | 25篇 |
1975年 | 21篇 |
1973年 | 16篇 |
排序方式: 共有9112条查询结果,搜索用时 15 毫秒
101.
Wang C Horiuchi A Imai T Ohira S Itoh K Nikaido T Katsuyama Y Konishi I 《The Journal of pathology》2004,202(2):215-223
BRCA1 is a putative tumour suppressor gene responsible for a hereditary ovarian cancer syndrome. To clarify the possible involvement of BRCA1 in the development of sporadic ovarian neoplasms, this study analysed the immunohistochemical expression of BRCA1 protein in normal ovarian surface epithelium and 119 epithelial ovarian tumours (19 benign, 24 borderline, and 76 malignant tumours). Loss of heterozygosity (LOH) of BRCA1 was examined using three microsatellite markers to analyse the relationship between BRCA1 expression and alterations of the BRCA1 gene. Methylation of the BRCA1 promoter was also analysed by methylation-specific PCR. In ovarian carcinomas showing heterogeneous expression of BRCA1 protein in the same tumour, LOH and methylation status were analysed using microdissection techniques. Finally, the relationship of BRCA1 expression or its genetic alteration to clinicopathological parameters and patient survival was analysed. Ovarian surface epithelial cells expressed BRCA1 protein. Decreased expression of BRCA1 was found in 16% of benign tumours, 38% of borderline tumours, and 72% of carcinomas. LOH of BRCA1 was demonstrated in no benign tumours, 15% of borderline tumours, and 66% of carcinomas. Methylation of BRCA1 was not detected in benign or borderline tumours, but was present in 31% of carcinomas. Reduced expression of BRCA1 correlated with the presence of gene methylation. The frequency of BRCA1 methylation and LOH was higher in serous carcinomas than in other types. In one of the three serous carcinomas that showed heterogeneous expression of BRCA1, BRCA1-positive borderline-like tumour cells were LOH-positive and methylation-negative, whereas adjacent BRCA1-negative carcinoma cells were LOH-positive and methylation-positive. The prognosis of carcinoma patients did not correlate with BRCA1 expression or genetic status. These findings suggest that reduced expression of BRCA1 protein along with genetic and epigenetic changes of the BRCA1 gene play an important role in the development of sporadic ovarian carcinomas, particularly those of serous histology. 相似文献
102.
103.
Ayres FM Narita M Takahashi M Alldawi L Liu A Osman Y Abe T Yano T Sakaue M Toba K Furukawa T Aizawa Y 《Immunological investigations》2003,32(4):219-227
Dendritic cells (DCs) are potent antigen presenting cells and possess a direct anti-tumor cytotoxic ability. Nevertheless, the mechanism of anti-tumor cytotoxicity by DCs and the methods for its evaluation are not fully elucidated. In order to clarify this mechanism of cytotoxicity, we examined the ability of DCs 1) to suppress [3H] thymidine (3H-TdR) uptake by tumor cells; 2) to induce cytolysis on 51Cr-labeled tumor cells; 3) and to induce DNA fragmentation on 3H-TdR labeled tumor cells (JAM test). Cytolysis and DNA fragmentation are markers of necrotic and apoptotic mechanisms of cytotoxicity in vitro, respectively. DCs inhibited approximately 38.6% to 54.8% of the growth of B4D6, NB4, U937, and Daudi cells as evaluated by the uptake of 3H-TdR. However no cytolysis was verified by 51Cr-release assay. On the other hand, cytotoxicity rates found using the JAM test ranged from 3 to 81% depending on the cell line and the effector to target cell ratio. The discrepancy of cytotoxicity between 51Cr-release assay and the JAM test may be due to the phagocytosis of apoptotic tumor cells or the absorption of released 51Cr by DCs surrounding the target cells. In conclusion, the JAM test was more sensitive than the 4-h and the 10-h 51Cr-release assay to investigate cytotoxicity mediated by DCs toward hematopoietic tumor cell lines in vitro. 相似文献
104.
Miki Kaneko Toshikazu Uchida Mitsuhiko Moriyama Yasuyuki Arakawa Toshio Shikata Kenichiro Gotoh Satoaki Mima 《Journal of medical virology》1995,47(3):204-208
A pathogenic role of precore-defective mutation in the onset of fulminant hepatitis B has been suggested. However, precore-defective mutants do not always cause fulminant hepatitis B and are not always isolated from affected patients. These findings strongly suggest the presence of some additional important mutations outside the precore region in fulminant hepatitis. In the present investigation an attempt was made to sequence the X open reading frame of hepatitis B virus DNA isolated from seven patients with fulminant hepatitis B and five patients with acute hepatitis B. The latter were used as controls. Since the X open reading frame encodes the X protein and contains the core promoter/enhancer II complex, some critical mutations may enhance or disrupt the replication and expression of hepatitis B virus DNA leading to fulminant hepatitis. A C-to-T substitution was found at nucleotide (nt) 1655, an A-to-T substitution at nt 1764 and a G-to-A substitution at nt 1766 in 4, 5 and 5 patients, respectively, out of the seven with fulminant hepatitis. These substitutions were not recognized in the patients with acute hepatitis. These mutations might change the function of the X protein and core promoter/enhancer II complex. It is suggested, therefore, that these mutations, as well as the precore-defective mutation, may play an important role in the pathogenesis of fulminant hepatitis. © Wiley-Liss, Inc. 相似文献
105.
HIV-1 黑龙江省分离株CHNHLJ03009包膜克隆及分析 总被引:3,自引:1,他引:3
目的 分析黑龙江省Ⅰ型人免疫缺陷病毒(human irnmunodeficiency virus type 1,HIV-1)原代分离株包膜糖蛋白的变异性及表型特征。方法从一名HIV阳性但未发病的感染者外周血单个核细胞提取DNA,采用保守引物进行HIV包膜直接克隆,进行序列分析及系统树分析。构建了一株带该包膜蛋白的伪病毒并利用表达CXCR4和CCR5的靶细胞进行了感染实验,观察该病毒包膜利用辅助受体的表型特征。结果共获得2个有功能全长env克隆,分别命名为CHNHIJ03009c34(GenBank序列号为AY905493)和CHNHIA03009c33。用全长env氨基酸序列与国内外分离株进行同源性比较分析发现,与分离株CHNHLJ03009c34的包膜同源性最高的病毒为云南的HIV-1 B’亚型分离株RIA2,同源性为91.52%。系统发育分析结果表明,该株为泰国B’亚型,与云南分离株RIA2的遗传距离最近。对包膜蛋白结构分析结果显示,分离株CHNHLJ03009c34包膜在抗原性和亲水性上与RIA2没有明显差别。感染性检测结果显示该病毒只能感染U87.CD4.CCR5细胞,不能感染U87.CD4.CX-CR4细胞。结论本研究从黑龙江省一名HIV-1阳性者克隆到HIV-1CHNHLJ03009病毒的包膜基因,该病毒属于B’亚型(泰国亚型),为R5亲嗜性毒株。该包膜基因克隆为首次报道的黑龙江分离株。 相似文献
106.
Izumi H Nobukawa B Takahashi K Kumasaka T Miyamoto H Yamazaki A Sonobe S Uekusa T Suda K 《Human pathology》2005,36(7):841-844
We report here 4 cases of multilocular thymic cysts (MTCs) with reactive lymphoid follicular hyperplasia. They were admitted to our hospital to examine anterior mediastinal masses demonstrated on chest computed tomographic scans. Three patients presented high-grade intermittent fever, and 2 patients were associated with Sjogren syndrome with elevated serum antinuclear antibody levels. All patients were subjected to extended thymectomy. Interestingly, their fever disappeared immediately after surgery. Histologically, the lesions were characterized by several cystic spaces separated by various thick walls with dense lymphoid tissue containing large reactive germinal centers. The inner cyst walls were lined by flattened cuboidal epithelia in some portions. Columnar epithelia with focal cilia were partially observed in 2 cases. These pathological findings led to a diagnosis of MTCs that were thought to result from cystic transformation of medullary duct derivatives by acquired inflammatory processes. The pathological findings, together with clinical courses of our cases, suggest that inflammation accompanied by autoimmune diseases may play, in part, an important role in the development of MTCs. 相似文献
107.
Hirose M Nishikawa A Shibutani M Imai T Shirai T 《Environmental and molecular mutagenesis》2002,39(2-3):271-278
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is one of the most prevalent carcinogenic heterocyclic amines in the environment, targeting the colon, prostate, pancreas, and mammary gland in rodents. Chemopreventive effects of synthetic and naturally occurring compounds on PhIP-induced rat mammary carcinogenesis were investigated in a series of experiments. In a PhIP feeding model, groups of 20-21 female F344 rats each, were treated with 0.02% PhIP alone or PhIP plus 0.5% 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), 1% green tea catechins, 1% alpha-tocopherol, 0.1% ellagic acid, or 1% chlorophyllin, each in the diet, or 0.1% caffeine in drinking water for 52 weeks. To assess the mechanism of HTHQ and caffeine inhibition of PhIP-induced carcinogenesis, effects of these compound on the in vitro metabolic activation of PhIP were examined in the presence of S9 mix. In the next series of experiments, the PhIP intragastric dose model was applied to allow separate investigation of the effects of chemicals during the initiation and postinitiation periods. In these experiments, female Sprague-Dawley rats were given eight intragastric doses of 100 mg/kg body weight during the first 4-8 weeks for initiation. Either during initiation or after initiation, or only after initiation, animals were treated with either corn or perilla oil at doses of 5 and 20%, conjugated fatty acid derived from safflower oil (CFA-S) or perilla oil (CFA-P) at a dose of 1%, arctiin at doses of 0.02 and 0.2% in the diet, or sodium nitrite (NaNO(2)) at a dose of 0.2% in drinking water. In the PhIP feeding model, administration of PhIP alone for 52 weeks induced adenocarcinomas in 40% of rats, but the incidence was remarkably reduced to 5% by the simultaneous treatment with 0.5% HTHQ, a strong lipophilic phenolic antioxidant, or to 10% by 0.1% caffeine. Administration of 1% chlorophyllin exerted similar, albeit weaker, effects. alpha-Tocopherol at a dose of 0.5% only reduced the multiplicity of carcinomas, and 1% green tea catechins only the mean size of mammary tumors. In a metabolic activation study of PhIP, HTHQ and caffeine clearly inhibited the formation of metabolites. In the PhIP gastric dose model, among the naturally occurring compounds examined, a plant lignan arctiin, perilla oil, which contains a large amount of n-6 alpha-linolenic acid, and CFA-S or CFA-P inhibited mammary tumor development, particularly in the postinitiation period, although a clear dose response was not observed. Treatment with 0.2% NaNO(2) in the initiation period was found to lower the volume of mammary tumors. The present results indicate that a number of compounds may be candidate chemopreventive agents against PhIP-induced mammary carcinogenesis, acting through different mechanisms and depending on the stage of carcinogenesis. 相似文献
108.
Immune Abnormalities Induced by Human Endogenous Retroviral Peptides: With Reference to the Pathogenesis of Systemic Lupus Erythematosus 总被引:1,自引:0,他引:1
Naito T Ogasawara H Kaneko H Hishikawa T Sekigawa I Hashimoto H Maruyama N 《Journal of clinical immunology》2003,23(5):371-376
P15E is a specific sequence among the envelope gene (env)-encoded transmembrane proteins of exogenous and endogenous retroviruses. A synthetic peptide (CKS-17) that shows homology to this p15E region in several species of retrovirus is known to induce immune abnormalities. In this study, we examined the effect of a synthetic peptide derived from a region of human endogenous retrovirus (HERV) clone 4-1 ( 4-1) similar to sequences of CKS-17 on the induction of systemic lupus erythematosus (SLE)-related immune abnormalities. Our results indicated that this peptide could induce T-cell activation and anergy in normal peripheral blood mononuclear cells, and the peptide could also promote the production of interleukins IL-6 and IL-16. These phenomena are representative immune abnormalities observed in SLE patients. Thus, our findings support the possibility that HERV acts as a pathogen in human SLE. 相似文献
109.
Takeaki Fukuda Yoshihisa Ohnishi Tomiyoshi Hasegawa Toshio Kakihara Hiroyuki Usuda 《Pathology international》1992,42(5):339-346
We have examined the distribution of antigens detected by MB1, MB2 and MB3 on non-hematopoietic normal human tissues and various types of benign and malignant tumors. MB1 and MB2 reacted with various organs, such as the epithelium of various glands, smooth muscle cells, vascular endothelial cells, and peripheral nerve tissue. The distributions of these two antibodies were essentially identical. Reactivity with MB3 was confined to the ductal eDithelium of salivary glands, the pancreas, and sweat glands, and the cortex of the adrenal gland. lmmunoblotting analysis demonstrated that MB1 and MB2 reacted with a few bands of an extract of myometrial cytoskeletal fraction and salivary gland cytosol fraction, whereas MB3 failed to show any bands on these materials. The reactivities of MB1 and MB2 with various neoplasms were similar to those in normal organs, with slight variations of staining pattern and preponderance in well differentiated tumors. Exceptionally, carcinoid tumor and small round cell tumors, such as small cell carcinoma or neuroblastoma, were not reactive with MB1 and MB2. MB3 reacted with several cases of well differentiated benign and malignant epithelial tumors in various organs, and exceptional cases of malignant schwannoma and glioma. These results indicate that the antigens detected by MB1 and MB2 are distributed broadly on non-hematopoietic normal organs, whereas those detected by MB3 are confined to exceptional cases of epithelial and non-epithelial tumors. Thus, although the use of MB1, MB2 and MB3 is of little value for differential diagnosis of various tumors, these three antibodies may be useful for determining of the origin of some tumor types. Acta Pathol Jpn 42: 339–346, 1992. 相似文献